Literature DB >> 1578926

The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. The German Adult ALL Study Group.

D Hoelzer, E Thiel, W D Ludwig, H Löffler, T Büchner, M Freund, G Heil, W Hiddemann, G Maschmeyer, B Völkers.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1578926

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  Analysis of 20-year follow-up study of LVP regimen for adult acute lymphoblastic leukemia.

Authors:  Y Hatta; J Takeuchi; T Ohshima; A Horikoshi; Y Iizuka; M Kawamura; M Kanemaru; T Horie
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

2.  Twenty-three cases of acute lymphoblastic leukemia with translocation t(4;11)(q21;q23): the implication of additional chromosomal aberrations.

Authors:  C Schoch; H Rieder; M Freund; D Hoelzer; H Riehm; C Fonatsch
Journal:  Ann Hematol       Date:  1995-04       Impact factor: 3.673

3.  High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma.

Authors:  R Willemze; J M Zijlmans; G J den Ottolander; J C Kluin-Nelemans; J H Falkenburg; C W Starrenburg; J F van der Burgh; W E Fibbe
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

4.  Acute lymphoblastic leukemia in patients over 59 years of age. Experience in a single center over a 10-year period.

Authors:  E Späth-Schwalbe; G Heil; H Heimpel
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

5.  Endocarditis and aortal embolization caused by Aspergillus terreus in a patient with acute lymphoblastic leukemia in remission: diagnosis by peripheral-blood culture.

Authors:  G Schett; B Casati; B Willinger; G Weinländer; T Binder; F Grabenwöger; W Sperr; K Geissler; U Jäger
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

Review 6.  Meningeosis leukaemica in adult acute lymphoblastic leukaemia.

Authors:  N Gökbuget; D Hoelzer
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

7.  High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL)--a single-institution study.

Authors:  R Scherrer; P Bettelheim; K Geissler; U Jäger; P Knöbl; P A Kyrle; K Laczika; G Mitterbauer; E Neumann; B Schneider
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

8.  Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.

Authors:  Hillard M Lazarus; Susan M Richards; Raj Chopra; Mark R Litzow; Alan K Burnett; Peter H Wiernik; Ian M Franklin; Martin S Tallman; Lucy Cook; Georgina Buck; I Jill Durrant; Jacob M Rowe; Anthony H Goldstone
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

9.  In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: implications for autologous BMT.

Authors:  H Martin; J Atta; J Bruecher; S Elsner; C Schardt; M Stadler; H von Melchner; D Hoelzer
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

10.  Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.

Authors:  Sook-Ryun Park; Jee Hyun Kim; Do Yeun Kim; Sehoon Lee; Sang-Yoon Lee; In Sil Choi; Sung-Soo Yoon; Seonyang Park; Byuoung-Gook Kim; Noe Kyoung Kim
Journal:  Korean J Intern Med       Date:  2003-03       Impact factor: 2.884
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.